Liposome-Hydrogel Hybrids: No Toil, No Trouble for Stronger Bubbles

Researchers at NIST, the University of Maryland (UM) and the U.S. Food and Drug Administration (FDA) have developed a method to combine liposomes and particles of hydrogel in a hybrid nanoscale particle that may one day travel directly to specific cells such as tumors, pass easily though the target's cell membrane, and then slowly release a drug payload.

Read the whole article on Newswise - Scinews

More from Newswise - Scinews